← Back to Clinical Trials
Recruiting NCT07294157

NCT07294157 Comparison of Rest Splints vs High-Intensity Laser Therapy in Carpal Tunnel Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07294157
Status Recruiting
Phase
Sponsor Afyonkarahisar Health Sciences University
Condition Carpal Tunnel Syndrome (CTS)
Study Type INTERVENTIONAL
Enrollment 78 participants
Start Date 2025-12-15
Primary Completion 2026-07-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Rest splint grouphigh-intensity laser therapy (HILT)sham high-intensity laser therapy (HILT)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 78 participants in total. It began in 2025-12-15 with a primary completion date of 2026-07-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to compare the effectiveness of rest splints and high-intensity laser therapy(HILT) added to physical therapy programs for patients with carpal tunnel syndrome in terms of pain, function, nerve conduction studies, and grip strength.

Eligibility Criteria

Inclusion Criteria: * Patients aged 18-75 years who have been diagnosed with carpal tunnel syndrome based on their medical history, physical examination, clinical findings, and electromyography(EMG) results, who have applied to the outpatient clinic for physical therapy, and who have no contraindications for treatment will be included in the study after obtaining their consent. Exclusion Criteria: * Diabetes Mellitus * Hypothyroidism * Acromegaly * Rheumatic Diseases * Polyneuropathy * Ipsilateral brachial plexopathy and traumatic nerve injury in the upper extremity * Previous injection into the carpal tunnel within the last 6 months and physical therapy * Pregnancy * History of malignant tumors * Patients with cochlear implants * Acquired Immunodeficiency Syndrome * History of neck and/or shoulder surgery * Corticosteroid consumption, analgesic medication use * Epilepsy * Skin lesion

Contact & Investigator

Central Contact

Ümit DÜNDAR, Profesor

✉ umitftr@yahoo.com

📞 05337494526

Principal Investigator

Ümit DÜNDAR, Profesor

PRINCIPAL INVESTIGATOR

AFYONKARAHİSAR HEALTH SCİENCES UNİVERSITY

Frequently Asked Questions

Who can join the NCT07294157 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Carpal Tunnel Syndrome (CTS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07294157 currently recruiting?

Yes, NCT07294157 is actively recruiting participants. Contact the research team at umitftr@yahoo.com for enrollment information.

Where is the NCT07294157 trial being conducted?

This trial is being conducted at Afyonkarahisar, Turkey (Türkiye), Afyonkarahisar, Turkey (Türkiye).

Who is sponsoring the NCT07294157 clinical trial?

NCT07294157 is sponsored by Afyonkarahisar Health Sciences University. The principal investigator is Ümit DÜNDAR, Profesor at AFYONKARAHİSAR HEALTH SCİENCES UNİVERSITY. The trial plans to enroll 78 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology